Ceo dr. johnson lau recuperating from covid at home

Buffalo, n.y., jan. 25, 2021 (globe newswire) -- athenex, inc., (nasdaq: atnx), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that its ceo and board chairman, dr. johnson lau, has been discharged from the hospital and is doing well recuperating at home. he continues to carry out the full duties and responsibilities of ceo and chairman of athenex.
ATNX Ratings Summary
ATNX Quant Ranking